-
A Bayesian location-scale joint model for time-to-event and multivariate longitudinal data with association based on within-individual variability
Authors:
Marco Palma,
Ruth H Keogh,
Siobhán B Carr,
Rhonda Szczesniak,
David Taylor-Robinson,
Angela M Wood,
Graciela Muniz-Terrera,
Jessica K Barrett
Abstract:
Within-individual variability of health indicators measured over time is becoming commonly used to inform about disease progression. Simple summary statistics (e.g. the standard deviation for each individual) are often used but they are not suited to account for time changes. In addition, when these summary statistics are used as covariates in a regression model for time-to-event outcomes, the est…
▽ More
Within-individual variability of health indicators measured over time is becoming commonly used to inform about disease progression. Simple summary statistics (e.g. the standard deviation for each individual) are often used but they are not suited to account for time changes. In addition, when these summary statistics are used as covariates in a regression model for time-to-event outcomes, the estimates of the hazard ratios are subject to regression dilution. To overcome these issues, a joint model is built where the association between the time-to-event outcome and multivariate longitudinal markers is specified in terms of the within-individual variability of the latter. A mixed-effect location-scale model is used to analyse the longitudinal biomarkers, their within-individual variability and their correlation. The time to event is modelled using a proportional hazard regression model, with a flexible specification of the baseline hazard, and the information from the longitudinal biomarkers is shared as a function of the random effects. The model can be used to quantify within-individual variability for the longitudinal markers and their association with the time-to-event outcome. We show through a simulation study the performance of the model in comparison with the standard joint model with constant variance. The model is applied on a dataset of adult women from the UK cystic fibrosis registry, to evaluate the association between lung function, malnutrition and mortality.
△ Less
Submitted 15 March, 2025;
originally announced March 2025.
-
Patient stratification in multi-arm trials: a two-stage procedure with Bayesian profile regression
Authors:
Yuejia Xu,
Angela M. Wood,
Brian D. M. Tom
Abstract:
Precision medicine is an emerging field that takes into account individual heterogeneity to inform better clinical practice. In clinical trials, the evaluation of treatment effect heterogeneity is an important component, and recently, many statistical methods have been proposed for stratifying patients into different subgroups based on such heterogeneity. However, the majority of existing methods…
▽ More
Precision medicine is an emerging field that takes into account individual heterogeneity to inform better clinical practice. In clinical trials, the evaluation of treatment effect heterogeneity is an important component, and recently, many statistical methods have been proposed for stratifying patients into different subgroups based on such heterogeneity. However, the majority of existing methods developed for this purpose focus on the case with a dichotomous treatment and are not directly applicable to multi-arm trials. In this paper, we consider the problem of patient stratification in multi-arm trial settings and propose a two-stage procedure within the Bayesian nonparametric framework. Specifically, we first use Bayesian additive regression trees (BART) to predict potential outcomes (treatment responses) under different treatment options for each patient, and then we leverage Bayesian profile regression to cluster patients into subgroups according to their baseline characteristics and predicted potential outcomes. We further embed a variable selection procedure into our proposed framework to identify the patient characteristics that actively "drive" the clustering structure. We conduct simulation studies to examine the performance of our proposed method and demonstrate the method by applying it to a UK-based multi-arm blood donation trial, wherein our method uncovers five clinically meaningful donor subgroups.
△ Less
Submitted 22 February, 2023;
originally announced February 2023.
-
Sequential Re-estimation Learning of Optimal Individualized Treatment Rules Among Ordinal Treatments with Application to Recommended Intervals Between Blood Donations
Authors:
Yuejia Xu,
Angela M. Wood,
David J. Roberts,
Brian D. M. Tom
Abstract:
Personalized medicine has gained much popularity recently as a way of providing better healthcare by tailoring treatments to suit individuals. Our research, motivated by the UK INTERVAL blood donation trial, focuses on estimating the optimal individualized treatment rule (ITR) in the ordinal treatment-arms setting. Restrictions on minimum lengths between whole blood donations exist to safeguard do…
▽ More
Personalized medicine has gained much popularity recently as a way of providing better healthcare by tailoring treatments to suit individuals. Our research, motivated by the UK INTERVAL blood donation trial, focuses on estimating the optimal individualized treatment rule (ITR) in the ordinal treatment-arms setting. Restrictions on minimum lengths between whole blood donations exist to safeguard donor health and quality of blood received. However, the evidence-base for these limits is lacking. Moreover, in England, the blood service is interested in making blood donation both safe and sustainable by integrating multi-marker data from INTERVAL and developing personalized donation strategies. As the three inter-donation interval options in INTERVAL have clear orderings, we propose a sequential re-estimation learning method that effectively incorporates "treatment" orderings when identifying optimal ITRs. Furthermore, we incorporate variable selection into our method for both linear and nonlinear decision rules to handle situations with (noise) covariates irrelevant for decision-making. Simulations demonstrate its superior performance over existing methods that assume multiple nominal treatments by achieving smaller misclassification rates and larger value functions. Application to a much-in-demand donor subgroup shows that the estimated optimal ITR achieves both the highest utilities and largest proportions of donors assigned to the safest inter-donation interval option in INTERVAL.
△ Less
Submitted 22 February, 2023;
originally announced February 2023.
-
Optimal risk-assessment scheduling for primary prevention of cardiovascular disease
Authors:
Francesca Gasperoni,
Christopher H. Jackson,
Angela M. Wood,
Michael J. Sweeting,
Paul J. Newcombe,
David Stevens,
Jessica K. Barrett
Abstract:
In this work, we introduce a personalised and age-specific Net Benefit function, composed of benefits and costs, to recommend optimal timing of risk assessments for cardiovascular disease prevention. We extend the 2-stage landmarking model to estimate patient-specific CVD risk profiles, adjusting for time-varying covariates. We apply our model to data from the Clinical Practice Research Datalink,…
▽ More
In this work, we introduce a personalised and age-specific Net Benefit function, composed of benefits and costs, to recommend optimal timing of risk assessments for cardiovascular disease prevention. We extend the 2-stage landmarking model to estimate patient-specific CVD risk profiles, adjusting for time-varying covariates. We apply our model to data from the Clinical Practice Research Datalink, comprising primary care electronic health records from the UK. We find that people at lower risk could be recommended an optimal risk-assessment interval of 5 years or more. Time-varying risk-factors are required to discriminate between more frequent schedules for higher-risk people.
△ Less
Submitted 9 February, 2023;
originally announced February 2023.
-
Population-calibrated multiple imputation for a binary/categorical covariate in categorical regression models
Authors:
Tra My Pham,
James R Carpenter,
Tim P Morris,
Angela M Wood,
Irene Petersen
Abstract:
Multiple imputation (MI) has become popular for analyses with missing data in medical research. The standard implementation of MI is based on the assumption of data being missing at random (MAR). However, for missing data generated by missing not at random (MNAR) mechanisms, MI performed assuming MAR might not be satisfactory. For an incomplete variable in a given dataset, its corresponding popula…
▽ More
Multiple imputation (MI) has become popular for analyses with missing data in medical research. The standard implementation of MI is based on the assumption of data being missing at random (MAR). However, for missing data generated by missing not at random (MNAR) mechanisms, MI performed assuming MAR might not be satisfactory. For an incomplete variable in a given dataset, its corresponding population marginal distribution might also be available in an external data source. We show how this information can be readily utilised in the imputation model to calibrate inference to the population, by incorporating an appropriately calculated offset termed the `calibrated-$δ$ adjustment'. We describe the derivation of this offset from the population distribution of the incomplete variable and show how in applications it can be used to closely (and often exactly) match the post-imputation distribution to the population level. Through analytic and simulation studies, we show that our proposed calibrated-$δ$ adjustment MI method can give the same inference as standard MI when data are MAR, and can produce more accurate inference under two general MNAR missingness mechanisms. The method is used to impute missing ethnicity data in a type 2 diabetes prevalence case study using UK primary care electronic health records, where it results in scientifically relevant changes in inference for non-White ethnic groups compared to standard MI. Calibrated-$δ$ adjustment MI represents a pragmatic approach for utilising available population-level information in a sensitivity analysis to explore potential departure from the MAR assumption.
△ Less
Submitted 4 May, 2018;
originally announced May 2018.